查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1221074

抗生劑抗性的全球市場:新抗生劑開發的研究開發投資增加，促進市場成長

Increasing Investment in R&D to Develop Novel Antibiotics Spurs Growth in Antibiotic Resistance Market
出版日期: | 出版商: Persistence Market Research | 英文 272 Pages | 商品交期: 2-5個工作天內

價格

本報告提供全球抗生劑抗性市場調查，市場結構相關詳細資訊，以及促進因素，趨勢，機會，阻礙因素，競爭情形等主要市場動態相關的詳細評估，及2023年～2033年預測期間內展望。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類法
  • 市場定義/範圍/限制
  • 納入和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新、開發趨勢

第4章 主要成功因素

  • 疾病流行病學
  • 產品採用分析
  • 產品USP分析
  • 所採用的主要策略:各製造廠商
  • 開發平台評估
  • 大環境分析
  • 波特分析
  • 法規情勢

第5章 市場背景

  • 宏觀經濟要素
    • 全球GDP預測
    • 全球生物醫藥品預測
  • 預測要素:相關性及影響
    • 主要企業的成長履歷
    • 院內感染的盛行率
    • 主要的法規
    • 政府資金
    • 償付政策
    • 研究開發的實踐的擴大
    • 細菌感染的發生率
    • 新產品的銷售與核准
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會分析

第6章 COVID-19危機

  • 2022年的市場情勢
  • COVID-19及影響分析
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 各銷售管道
    • 各地區

第7章 全球抗生劑抗性市場:需求分析、預測

  • 過去的市場分析
  • 現在及未來市場預測
    • 與前一年同期比較成長趨勢分析

第8章 全球抗生劑抗性市場分析、預測:各類藥物

  • 簡介/主要的調查結果
  • 過去的市場分析:醫藥品分類
  • 現在及未來市場分析、預測:各類藥物
    • β-內醯胺抗生劑
    • 頭孢菌素
    • 奎諾酮系抗生劑
    • 大環內酯類系抗生劑
    • 四環黴素系
    • Oxazolidinone
    • 其他
  • 市場魅力分析:各類藥物

第9章 全球抗生劑抗性市場分析、預測:病原體

  • 簡介/主要的調查結果
  • 過去的市場分析:病原體
  • 現在及未來市場分析、預測:病原體
    • 金黃色葡萄球菌
    • 肺炎鏈球菌
    • 淋病雙球菌
    • 糞腸球菌
    • 大腸桿菌
    • 肺炎克雷伯氏菌
    • 志賀氏桿菌
    • 難辨梭狀芽孢桿菌
    • 其他
  • 市場魅力分析:病原體

第10章 全球抗生劑抗性市場分析、預測:各疾病

  • 簡介/主要的調查結果
  • 過去的市場分析:各疾病
  • 現在及未來市場分析、預測:各疾病
    • 社區肺炎性細菌性肺炎(CABP)
    • 院內細菌性肺炎/人工呼吸器(HABP/VABP)
    • 複雜性泌尿道感染(CUTI)
    • 複雜性腹腔內感染疾病(CIAI)
    • 血流感染疾病(BSI)
    • 腹部感染疾病、腹瀉症(難辨梭狀芽孢桿菌傳染病(CDI)及赤痢菌)
    • 急性細菌性皮膚、皮膚結構感染疾病(ABSSSI)
    • 藥物抗性淋菌
  • 市場魅力分析:各疾病

第11章 全球抗生劑抗性市場分析、預測:各作用機制

  • 簡介/主要的調查結果
  • 過去的市場分析:各作用機制
  • 現在及未來市場分析、預測:各作用機制
    • 細胞牆合成抑制劑
    • 蛋白質合成抑制劑
    • DNA合成抑制劑
    • RNA合成抑制劑
    • 其他
  • 市場魅力分析:各作用機制

第12章 全球抗生劑抗性市場分析、預測:各流通管道

  • 簡介/主要的調查結果
  • 過去的市場分析:各流通管道
  • 現在及未來市場分析、預測:各流通管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力分析:各流通管道

第13章 全球抗生劑抗性市場分析、預測:各地區

  • 簡介
  • 過去的市場分析:各地區
  • 目前市場分析、預測:各地區
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東、非洲
  • 市場魅力分析:各地區

第14章 北美的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 美國的抗生劑抗性市場
    • 加拿大的抗生劑抗性市場

第15章 南美的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 巴西的抗生劑抗性市場
    • 阿根廷的抗生劑抗性市場
    • 墨西哥的抗生劑抗性市場

第16章 歐洲的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 德國的抗生劑抗性市場
    • 法國的抗生劑抗性市場
    • 義大利的抗生劑抗性市場
    • 西班牙的抗生劑抗性市場
    • 英國的抗生劑抗性市場
    • 荷比盧三國的抗生劑抗性市場
    • 俄羅斯的抗生劑抗性市場

第17章 南亞的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 印度的抗生劑抗性市場
    • 印尼的抗生劑抗性市場
    • 馬來西亞的抗生劑抗性市場
    • 泰國的抗生劑抗性市場

第18章 東亞的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 中國的抗生劑抗性市場
    • 日本的抗生劑抗性市場
    • 韓國的抗生劑抗性市場

第19章 大洋洲的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • 澳洲的抗生劑抗性市場
    • 紐西蘭的抗生劑抗性市場

第20章 中東、非洲的抗生劑抗性市場:分析、預測

  • 簡介
  • 過去的市場趨勢分析:各市場分類
  • 現在及未來市場分析、預測:各市場分類
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 市場魅力分析
    • 各國
    • 各類藥物
    • 各病原體
    • 各疾病
    • 各作用機制
    • 通路
  • 主要的市場參與企業:強度製圖
  • 促進因素與阻礙因素:影響分析
  • 國家等級的分析、預測
    • GCC各國的抗生劑抗性市場
    • 土耳其的抗生劑抗性市場
    • 南非的抗生劑抗性市場
    • 北非的抗生劑抗性市場

第21章 市場結構分析

  • 市場分析:企業層
  • 主要企業的市場佔有率分析
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳細內容
    • Merck KgaA
    • Bio-Rad Laboratories, Inc.
    • Takara Bio, Inc.
    • QIAGEN N.V.
    • Pall Corporation
    • Eppendorf Corporate
    • Tarsons Products PVT. LTD.
    • Applied Biological Materials Inc.
    • Greiner AG
    • Brooks Life Sciences
    • Corning Incorporated
    • Cytiva
    • PerkinElmer

第23章 前提條件與縮寫

第24章 調查手法

Product Code: PMRREP27895

Antibiotic Resistance Market: Scope of the Report

The latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the antibiotic resistance market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the antibiotic resistance market offers information divided into six important segments -drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Beta Lactum Antibiotic

Cephalosporins

Quinolones Antibiotics

Macrolide Antibiotics

Tetracyclines

Oxazolidinones

Others

Pathogen

Staphylococcus aureus

Streptococcus pneumonia

Neisseria gonorrhoeae

Enterococcus faecium

Escherichia coli

Klebsiella Pneumonia

Shigella

Clostridium difficile

Others

Disease

Community Acquired Bacterial Pneumonia (CABP)

Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)

Complicated Urinary Tract Infections (CUTI)

Complicated Intra-Abdominal Infections (CIAI)

Blood Stream Infections (BSI)

Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Drug Resistant Gonorrhoeae

Mechanism of Action

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Others

Distribution channel

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for antibiotic resistance over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis impacted market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the antibiotic resistance market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the antibiotic resistance market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Disease Epidemiology
  • 4.2. Product Adoption Analysis
  • 4.3. Product USPs Analysis
  • 4.4. Key Strategies Adopted by Manufactures
  • 4.5. Pipeline Assessment
  • 4.6. PESTLE Analysis
  • 4.7. Porters Analysis
  • 4.8. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Biopharmaceutical Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Prevalence of Hospital-Acquired Infections
    • 5.2.3. Key Regulations
    • 5.2.4. Government Funding
    • 5.2.5. Reimbursement Policy
    • 5.2.6. Growing R&D Practices
    • 5.2.7. Incidence of Bacterial Infections
    • 5.2.8. New Product Launches and Approvals
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis

  • 6.1. 2022 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Drug Class
    • 6.2.2. By Pathogen
    • 6.2.3. By Disease
    • 6.2.4. By Mechanism of Action
    • 6.2.5. By Distribution channel
    • 6.2.6. By Region

7. Global Antibiotic Resistance Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Drug Class

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2023-2033
    • 8.3.1. Beta Lactum Antibiotic
    • 8.3.2. Cephalosporins
    • 8.3.3. Quinolones Antibiotics
    • 8.3.4. Macrolide Antibiotics
    • 8.3.5. Tetracyclines
    • 8.3.6. Oxazolidinones
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis By Drug Class

9. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Pathogen

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2023-2033
    • 9.3.1. Staphylococcus aureus
    • 9.3.2. Streptococcus pneumonia
    • 9.3.3. Neisseria gonorrhoeae
    • 9.3.4. Enterococcus faecium
    • 9.3.5. Escherichia coli
    • 9.3.6. Klebsiella Pneumonia
    • 9.3.7. Shigella
    • 9.3.8. Clostridium difficile
    • 9.3.9. Others
  • 9.4. Market Attractiveness Analysis By Pathogen

10. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Disease

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Disease, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023-2033
    • 10.3.1. Community Acquired Bacterial Pneumonia (CABP)
    • 10.3.2. Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
    • 10.3.3. Complicated Urinary Tract Infections (CUTI)
    • 10.3.4. Complicated Intra-Abdominal Infections (CIAI)
    • 10.3.5. Blood Stream Infections (BSI)
    • 10.3.6. Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)
    • 10.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    • 10.3.8. Drug Resistant Gonorrhoeae
  • 10.4. Market Attractiveness Analysis By Disease

11. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Mechanism of Action

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2015-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2023-2033
    • 11.3.1. Cell Wall Synthesis Inhibitors
    • 11.3.2. Protein Synthesis Inhibitors
    • 11.3.3. DNA Synthesis Inhibitors
    • 11.3.4. RNA Synthesis Inhibitors
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis By Mechanism of Action

12. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Distribution channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Distribution channel, 2015-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution channel, 2023-2033
    • 12.3.1. Hospitals Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Market Attractiveness Analysis By Distribution channel

13. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Drug Class
    • 14.3.3. By Pathogen
    • 14.3.4. By Disease
    • 14.3.5. By Mechanism of Action
    • 14.3.6. Distribution channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug Class
    • 14.4.3. By Pathogen
    • 14.4.4. By Disease
    • 14.4.5. By Mechanism of Action
    • 14.4.6. Distribution channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Antibiotic Resistance Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Drug Class
        • 14.7.1.2.2. By Pathogen
        • 14.7.1.2.3. By Disease
        • 14.7.1.2.4. By Mechanism of Action
        • 14.7.1.2.5. Distribution channel
    • 14.7.2. Canada Antibiotic Resistance Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Drug Class
        • 14.7.2.2.2. By Pathogen
        • 14.7.2.2.3. By Disease
        • 14.7.2.2.4. By Mechanism of Action
        • 14.7.2.2.5. Distribution channel

15. Latin America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Rest of Latin America
    • 15.3.2. By Drug Class
    • 15.3.3. By Pathogen
    • 15.3.4. By Disease
    • 15.3.5. By Mechanism of Action
    • 15.3.6. Distribution channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug Class
    • 15.4.3. By Pathogen
    • 15.4.4. By Disease
    • 15.4.5. By Mechanism of Action
    • 15.4.6. Distribution channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Antibiotic Resistance Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Drug Class
        • 15.7.1.2.2. By Pathogen
        • 15.7.1.2.3. By Disease
        • 15.7.1.2.4. By Mechanism of Action
        • 15.7.1.2.5. Distribution channel
    • 15.7.2. Argentina Antibiotic Resistance Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Drug Class
        • 15.7.2.2.2. By Pathogen
        • 15.7.2.2.3. By Disease
        • 15.7.2.2.4. By Mechanism of Action
        • 15.7.2.2.5. Distribution channel
    • 15.7.3. Mexico Antibiotic Resistance Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Drug Class
        • 15.7.3.2.2. By Pathogen
        • 15.7.3.2.3. By Disease
        • 15.7.3.2.4. By Mechanism of Action
        • 15.7.3.2.5. Distribution channel

16. Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Drug Class
    • 16.3.3. By Pathogen
    • 16.3.4. By Disease
    • 16.3.5. By Mechanism of Action
    • 16.3.6. Distribution channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug Class
    • 16.4.3. By Pathogen
    • 16.4.4. By Disease
    • 16.4.5. By Mechanism of Action
    • 16.4.6. Distribution channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Antibiotic Resistance Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Drug Class
        • 16.7.1.2.2. By Pathogen
        • 16.7.1.2.3. By Disease
        • 16.7.1.2.4. By Mechanism of Action
        • 16.7.1.2.5. Distribution channel
    • 16.7.2. France Antibiotic Resistance Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Drug Class
        • 16.7.2.2.2. By Pathogen
        • 16.7.2.2.3. By Disease
        • 16.7.2.2.4. By Mechanism of Action
        • 16.7.2.2.5. Distribution channel
    • 16.7.3. Italy Antibiotic Resistance Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Drug Class
        • 16.7.3.2.2. By Pathogen
        • 16.7.3.2.3. By Disease
        • 16.7.3.2.4. By Mechanism of Action
        • 16.7.3.2.5. Distribution channel
    • 16.7.4. Spain Antibiotic Resistance Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Drug Class
        • 16.7.4.2.2. By Pathogen
        • 16.7.4.2.3. By Disease
        • 16.7.4.2.4. By Mechanism of Action
        • 16.7.4.2.5. Distribution channel
    • 16.7.5. U.K. Antibiotic Resistance Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Drug Class
        • 16.7.5.2.2. By Pathogen
        • 16.7.5.2.3. By Disease
        • 16.7.5.2.4. By Mechanism of Action
        • 16.7.5.2.5. Distribution channel
    • 16.7.6. BENELUX Union Antibiotic Resistance Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Drug Class
        • 16.7.6.2.2. By Pathogen
        • 16.7.6.2.3. By Disease
        • 16.7.6.2.4. By Mechanism of Action
        • 16.7.6.2.5. Distribution channel
    • 16.7.7. Russia Antibiotic Resistance Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Drug Class
        • 16.7.7.2.2. By Pathogen
        • 16.7.7.2.3. By Disease
        • 16.7.7.2.4. By Mechanism of Action
        • 16.7.7.2.5. Distribution channel

17. South Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Drug Class
    • 17.3.3. By Pathogen
    • 17.3.4. By Disease
    • 17.3.5. By Mechanism of Action
    • 17.3.6. Distribution channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug Class
    • 17.4.3. By Pathogen
    • 17.4.4. By Disease
    • 17.4.5. By Mechanism of Action
    • 17.4.6. Distribution channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Antibiotic Resistance Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Drug Class
        • 17.7.1.2.2. By Pathogen
        • 17.7.1.2.3. By Disease
        • 17.7.1.2.4. By Mechanism of Action
        • 17.7.1.2.5. Distribution channel
    • 17.7.2. Indonesia Antibiotic Resistance Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Drug Class
        • 17.7.2.2.2. By Pathogen
        • 17.7.2.2.3. By Disease
        • 17.7.2.2.4. By Mechanism of Action
        • 17.7.2.2.5. Distribution channel
    • 17.7.3. Malaysia Antibiotic Resistance Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Drug Class
        • 17.7.3.2.2. By Pathogen
        • 17.7.3.2.3. By Disease
        • 17.7.3.2.4. By Mechanism of Action
        • 17.7.3.2.5. Distribution channel
    • 17.7.4. Thailand Antibiotic Resistance Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Drug Class
        • 17.7.4.2.2. By Pathogen
        • 17.7.4.2.3. By Disease
        • 17.7.4.2.4. By Mechanism of Action
        • 17.7.4.2.5. Distribution channel

18. East Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Drug Class
    • 18.3.3. By Pathogen
    • 18.3.4. By Disease
    • 18.3.5. By Mechanism of Action
    • 18.3.6. Distribution channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug Class
    • 18.4.3. By Pathogen
    • 18.4.4. By Disease
    • 18.4.5. By Mechanism of Action
    • 18.4.6. Distribution channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Antibiotic Resistance Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Drug Class
        • 18.7.1.2.2. By Pathogen
        • 18.7.1.2.3. By Disease
        • 18.7.1.2.4. By Mechanism of Action
        • 18.7.1.2.5. Distribution channel
    • 18.7.2. Japan Antibiotic Resistance Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Drug Class
        • 18.7.2.2.2. By Pathogen
        • 18.7.2.2.3. By Disease
        • 18.7.2.2.4. By Mechanism of Action
        • 18.7.2.2.5. Distribution channel
    • 18.7.3. South Korea Antibiotic Resistance Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Drug Class
        • 18.7.3.2.2. By Pathogen
        • 18.7.3.2.3. By Disease
        • 18.7.3.2.4. By Mechanism of Action
        • 18.7.3.2.5. Distribution channel

19. Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Drug Class
    • 19.3.3. By Pathogen
    • 19.3.4. By Disease
    • 19.3.5. By Mechanism of Action
    • 19.3.6. Distribution channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Drug Class
    • 19.4.3. By Pathogen
    • 19.4.4. By Disease
    • 19.4.5. By Mechanism of Action
    • 19.4.6. Distribution channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Antibiotic Resistance Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Drug Class
        • 19.7.1.2.2. By Pathogen
        • 19.7.1.2.3. By Disease
        • 19.7.1.2.4. By Mechanism of Action
        • 19.7.1.2.5. Distribution channel
    • 19.7.2. New Zealand Antibiotic Resistance Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Drug Class
        • 19.7.2.2.2. By Pathogen
        • 19.7.2.2.3. By Disease
        • 19.7.2.2.4. By Mechanism of Action
        • 19.7.2.2.5. Distribution channel

20. Middle East and Africa (MEA) Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Drug Class
    • 20.3.3. By Pathogen
    • 20.3.4. By Disease
    • 20.3.5. By Mechanism of Action
    • 20.3.6. Distribution channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Drug Class
    • 20.4.3. By Pathogen
    • 20.4.4. By Disease
    • 20.4.5. By Mechanism of Action
    • 20.4.6. Distribution channel
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Antibiotic Resistance Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Drug Class
        • 20.7.1.2.2. By Pathogen
        • 20.7.1.2.3. By Disease
        • 20.7.1.2.4. By Mechanism of Action
        • 20.7.1.2.5. Distribution channel
    • 20.7.2. Turkey Antibiotic Resistance Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Drug Class
        • 20.7.2.2.2. By Pathogen
        • 20.7.2.2.3. By Disease
        • 20.7.2.2.4. By Mechanism of Action
        • 20.7.2.2.5. Distribution channel
    • 20.7.3. South Africa Antibiotic Resistance Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Drug Class
        • 20.7.3.2.2. By Pathogen
        • 20.7.3.2.3. By Disease
        • 20.7.3.2.4. By Mechanism of Action
        • 20.7.3.2.5. Distribution channel
    • 20.7.4. North Africa Antibiotic Resistance Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Drug Class
        • 20.7.4.2.2. By Pathogen
        • 20.7.4.2.3. By Disease
        • 20.7.4.2.4. By Mechanism of Action
        • 20.7.4.2.5. Distribution channel

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive

        22.3.1.Thermo Fisher Scientific, Inc.

      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Development
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Merck KgaA
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Development
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Bio-Rad Laboratories, Inc.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Development
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Takara Bio, Inc.
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Development
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. QIAGEN N.V.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Development
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Pall Corporation
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Development
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Eppendorf Corporate
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Development
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Tarsons Products PVT. LTD.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Development
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Applied Biological Materials Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Development
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Greiner AG
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Development
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Brooks Life Sciences
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Development
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. Corning Incorporated
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Development
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Cytiva
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Development
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. PerkinElmer
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Development
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

  • Table 01: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 02: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 03: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 04: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 05: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 06: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Region
  • Table 07: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 10: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 13: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 14: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 17: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 19: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 20: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 21: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 22: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 23: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 24: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 25: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 26: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 27: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 28: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 29: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 30: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 31: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 36: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 37: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 38: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 39: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 40: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 41: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 42: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 43: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 44: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 45: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 46: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 47: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 48: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel

List of Figures

  • Figure 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 02: Global Antibiotic Resistance Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 04: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Drug Class
  • Figure 05: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Drug Class
  • Figure 06: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Drug Class
  • Figure 07: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Pathogen
  • Figure 08: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Pathogen
  • Figure 09: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Pathogen
  • Figure 10: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Disease
  • Figure 11: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Disease
  • Figure 12: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Disease
  • Figure 13: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Mechanism of Action
  • Figure 14: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Mechanism of Action
  • Figure 15: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Mechanism of Action
  • Figure 16: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Distribution channel
  • Figure 17: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution channel
  • Figure 18: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Distribution channel
  • Figure 19: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 20: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 21: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Region
  • Figure 22: North America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 23: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 24: North America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 25: North America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 26: North America Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 27: North America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 28: North America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 29: North America Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 30: North America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 31: North America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 32: North America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 33: North America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 34: North America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 35: North America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 36: U.S. Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 37: Global Vs. U.S. Growth Comparison, 2022 - 2033
  • Figure 38: U.S. Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 39: U.S. Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 40: U.S. Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 41: U.S. Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 42: U.S. Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 43: Canada Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 44: Global Vs. Canada. Growth Comparison, 2022 - 2033
  • Figure 45: Canada Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 46: Canada Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 47: Canada Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 48: Canada Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 49: Canada Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 50: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 51: Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 52: Latin America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 53: Latin America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 54: Latin America Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 55: Latin America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 56: Latin America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 57: Latin America Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 58: Latin America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 59: Latin America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 60: Latin America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 61: Latin America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 62: Latin America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 63: Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 64: Mexico Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 65: Global Vs Mexico Growth Comparison, 2022 - 2033
  • Figure 66: Mexico Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 67: Mexico Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 68: Mexico Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 69: Mexico Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 70: Mexico Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 71: Brazil Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs. Brazil. Growth Comparison, 2022 - 2033
  • Figure 73: Brazil Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 74: Brazil Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 75: Brazil Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 76: Brazil Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 77: Brazil Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 78: Argentina Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 79: Global Vs Argentina Growth Comparison, 2022 - 2033
  • Figure 80: Argentina Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 81: Argentina Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 82: Argentina Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 83: Argentina Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 84: Argentina Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 85: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 86: Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 87: Europe Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 88: Europe Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 89: Europe Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 90: Europe Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 91: Europe Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 92: Europe Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 93: Europe Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 94: Europe Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 95: Europe Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 96: Europe Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 97: Europe Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 98: Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 99: UK Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 100: Global Vs. UK Growth Comparison, 2022 - 2033
  • Figure 101: UK Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 102: UK Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 103: UK Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 104: UK Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 105: UK Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 106: Germany Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 107: Global Vs. Germany Growth Comparison, 2022 - 2033
  • Figure 108: Germany Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 109: Germany Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 110: Germany Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 111: Germany Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 112: Germany Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 113: Italy Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 114: Global Vs. Italy Growth Comparison, 2022 - 2033
  • Figure 115: Italy Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 116: Italy Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 117: Italy Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 118: Italy Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 119: Italy Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 120: France Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 121: Global Vs France Growth Comparison, 2022 - 2033
  • Figure 122: France Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 123: France Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 124: France Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 125: France Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 126: France Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 127: Spain Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 128: Global Vs Spain Growth Comparison, 2022 - 2033
  • Figure 129: Spain Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 130: Spain Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 131: Spain Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 132: Spain Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 133: Spain Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 134: Russia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 135: Global Vs Russia Growth Comparison, 2022 - 2033
  • Figure 136: Russia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 137: Russia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 138: Russia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 139: Russia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 140: Russia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 141: BENELUX Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 142: Global Vs BENELUX Growth Comparison, 2022 - 2033
  • Figure 143: BENELUX Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 144: BENELUX Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 145: BENELUX Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 146: BENELUX Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 147: BENELUX Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 148: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 149: East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 150: East Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 151: East Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 152: East Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 153: East Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 154: East Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 155: East Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 156: East Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 157: East Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 158: East Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 159: East Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 160: East Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 161: East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 162: China Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 163: Global Vs. China Growth Comparison, 2022 - 2033
  • Figure 164: China Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 165: China Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 166: China Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 167: China Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 168: China Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 169: Japan Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 170: Global Vs. Japan Growth Comparison, 2022 - 2033
  • Figure 171: Japan Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 172: Japan Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 173: Japan Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 174: Japan Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 175: Japan Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 176: South Korea Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 177: Global Vs South Korea Growth Comparison, 2022 - 2033
  • Figure 178: South Korea Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 179: South Korea Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 180: South Korea Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 181: South Korea Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 182: South Korea Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 183: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 184: South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 185: South Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 186: South Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 187: South Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 188: South Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 189: South Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 190: South Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 191: South Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 192: South Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 193: South Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 194: South Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 195: South Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 196: South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 197: India Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 198: Global Vs. India Growth Comparison, 2022 - 2033
  • Figure 199: India Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 200: India Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 201: India Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 202: India Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 203: India Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 204: Indonesia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 205: Global Vs. Indonesia Growth Comparison, 2022 - 2033
  • Figure 206: Indonesia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 207: Indonesia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 208: Indonesia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 209: Indonesia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 210: Indonesia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 211: Malaysia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 212: Global Vs. Malaysia Growth Comparison, 2022 - 2033
  • Figure 213: Malaysia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 214: Malaysia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 215: Malaysia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 216: Malaysia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 217: Malaysia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 218: Thailand Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 219: Global Vs. Thailand Growth Comparison, 2022 - 2033
  • Figure 220: Thailand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 221: Thailand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 222: Thailand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 223: Thailand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 224: Thailand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 225: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 226: Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 227: Oceania Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 228: Oceania Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 229: Oceania Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 230: Oceania Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 231: Oceania Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 232: Oceania Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 233: Oceania Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 234: Oceania Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 235: Oceania Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 236: Oceania Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 237: Oceania Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 238: Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 239: Australia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 240: Global Vs. Australia Growth Comparison, 2022 - 2033
  • Figure 241: Australia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 242: Australia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 243: Australia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 244: Australia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 245: Australia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 246: New Zealand Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 247: Global Vs New Zealand Growth Comparison, 2022 - 2033
  • Figure 248: New Zealand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 249: New Zealand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 250: New Zealand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 251: New Zealand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 252: New Zealand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 253: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 254: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 255: Middle East & Africa Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 256: Middle East & Africa Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 257: Middle East & Africa Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 258: Middle East & Africa Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 259: Middle East & Africa Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 260: Middle East & Africa Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 261: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 262: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 263: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 264: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 265: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 266: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 267: GCC Countries Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 268: Global Vs GCC Countries Growth Comparison, 2022 - 2033
  • Figure 269: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 270: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 271: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 272: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 273: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 274: Turkey Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 275: Global Vs. Turkey Growth Comparison, 2022 - 2033
  • Figure 276: Turkey Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 277: Turkey Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 278: Turkey Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 279: Turkey Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 280: Turkey Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 281: South Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 282: Global Vs. South Africa Growth Comparison, 2022 - 2033
  • Figure 283: South Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 284: South Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 285: South Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 286: South Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 287: South Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 288: North Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 289: Global Vs North Africa Growth Comparison, 2022 - 2033
  • Figure 290: North Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 291: North Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 292: North Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 293: North Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 294: North Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033